Testing effectiveness (Phase 2)WithdrawnNCT02578121What this trial is testingUARK 2015-03 A Phase II Trial of a Novel Proteasome/IMiD CombinationWho this might be right forMultiple Myeloma University of Arkansas
Testing effectiveness (Phase 2)Active Not RecruitingNCT05955508What this trial is testingA Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Adult Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple MyelomaWho this might be right forSmoldering Multiple Myeloma (SMM) Regeneron Pharmaceuticals 40
Early research (Phase 1)Looking for participantsNCT07075185What this trial is testingEvaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple MyelomaWho this might be right forMultiple Myeloma in RelapseMyeloma MultipleMultiple Myeloma Progression+11 more Kelonia Therapeutics, Inc. 70
Not applicableUnknownNCT05477797What this trial is testingId and Rd Maintenance Regimens After Induction of Remission in Multiple Myeloma.Who this might be right forProgression Free SurvivalOverall SurvivalMaintenance RenJi Hospital 420
Early research (Phase 1)Not Yet RecruitingNCT07622862What this trial is testingExploratory Clinical Trial of DQ1001 in Relapsed or Refractory Multiple Myeloma (RRMM)Who this might be right forMultiple Myeloma RefractoryMultiple Myeloma Progression Zhongshan Hospital (Xiamen), Fudan University 16
Testing effectiveness (Phase 2)Study completedNCT00908232What this trial is testingTreatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VDWho this might be right forMultiple Myeloma Janssen-Cilag International NV 163
Testing effectiveness (Phase 2)Study completedNCT00823524What this trial is testingDonor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more Asan Medical Center 47
Not applicableStudy completedNCT01958528What this trial is testingStudy Of Circulating Multiple Myeloma Cells As A Biomarker of MGUS And SMMWho this might be right fora Diagnosis of MGUS or SMM by IMWG Criteria Abramson Cancer Center at Penn Medicine 52
Not applicableStudy completedNCT05712967What this trial is testingRole of the Host Microbiota and Il-17 in Favoring Multiple Myeloma ProgressionWho this might be right forMultiple Myeloma IRCCS San Raffaele 62
Early research (Phase 1)UnknownNCT03672253What this trial is testingCAR-T Re-treatment for Refractory/Relapsed Multiple MyelomaWho this might be right forMultiple MyelomaMultiple Myeloma in RelapseMultiple Myeloma Progression Second Affiliated Hospital of Xi'an Jiaotong University 20
Testing effectiveness (Phase 2)Ended earlyNCT03687125What this trial is testingTinostamustine Conditioning and Autologous Stem CellWho this might be right forMultiple Myeloma in RelapseMultiple Myeloma ProgressionMultiple Myeloma With Failed Remission Mundipharma-EDO GmbH 6
Not applicableStudy completedNCT00911105What this trial is testingNon -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and DexamethasoneWho this might be right forMultiple Myeloma iOMEDICO AG 101
Not applicableLooking for participantsNCT06252792What this trial is testingDara-PD in the Treatment of Patients With First Relapse of Multiple MyelomaWho this might be right forMultiple MyelomaFirst Relapse FengYan Jin 50
Not applicableNot Yet RecruitingNCT07634263What this trial is testingWhy Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods StudyWho this might be right forMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaMultiple Myeloma ProgressionMultiple Myeloma Refractory Odense University Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00027820What this trial is testingTotal-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerWho this might be right forAdult Acute Myeloid Leukemia in RemissionChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in Remission+27 more Fred Hutchinson Cancer Center 106
Not applicableUnknownNCT04364724What this trial is testingCTFEA Myeloma StudyWho this might be right forMyeloma MultipleMetastatic Bone Tumor Tel-Aviv Sourasky Medical Center 200
Not applicableEnded earlyNCT01927718What this trial is testingThalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT)Who this might be right forMyeloma M.D. Anderson Cancer Center 10
Not applicableStudy completedNCT05673967What this trial is testingReal-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple MyelomaWho this might be right forRelapsed and Refractory Multiple Myeloma (RRMM) Regeneron Pharmaceuticals 62
Not applicableEnrolling By InvitationNCT03689595What this trial is testingPredicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)Who this might be right forMultiple Myeloma Dana-Farber Cancer Institute 30,000
Not applicableLooking for participantsNCT06485076What this trial is testingEarly Palliative Care for Patients With Multiple Myeloma and Aggressive LymphomaWho this might be right forMultiple Myeloma in RelapseMultiple Myeloma, RefractoryMultiple Myeloma Stage III+5 more University Health Network, Toronto 144